Innovation Strategies and Competitive Advantage of Manufacturing Pharmaceutical Companies in Nairobi, Kenya
Year: 2018
Type: dissertation
Abstract: The growing number of traditional and herbal medicinal products has increased \ncompetition for pharmaceutical companies too. About 70% of the population in \nKenya relies on traditional medicine. This trend is worrying to the entire \npharmaceutical industry especially those manufacturing pharmaceutical companies. It \nis a threat to their competitive advantage and long-term survival. The study examined \nthe link between innovation strategies and competitive advantage among companies \nengaged in the manufacture of health care products. The design adopted was \ndescriptive. The population comprised of 22 manufacturing pharmaceutical \ncompanies in Nairobi. The study adopted a census on all the 22 companies. Data for \nthe study was sought by the use of questionnaires. The presentation of the findings \nwas done using tables. The study established that (88.0%) change in competitive \nadvantage of the studied manufacturing pharmaceutical companies is explained by \ntheir innovation strategies in place (process, product, technology and market \ninnovation). The study concludes that innovation strategies significantly influence \ncompetitive advantage. As a recommendation, the management of all manufacturing \npharmaceutical firms need to improve on their process, product and technology and \nmarket innovation in order to significantly influence competitive advantage of their \ncompanies. Policy makers including the ministry of health and the PPB of Kenya \nshould create a conducive environment that encourage and support innovation among \nmanufacturing pharmaceutical companies.
Author: Yussuf A Dore
Language: English
Subfield: Strategy and Management
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W2918736358